Results 251 to 260 of about 379,550 (314)

"My Sensory Experiences Tool": A Neurodiversity-Affirming Therapeutic Tool to Support the Sensory Challenges and Preferences of Autistic Children and Adults. [PDF]

Occup Ther Int
Ashburner J, Tomkins V, Downing C, Reitberg E, Hill J, Copley J, Bobir N.   +6 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

A Multi-Fish Tracking and Behavior Modeling Framework for High-Density Cage Aquaculture. [PDF]

Sensors (Basel)
Xiao X, Liu T, He S, Li P, Gu Y, Li P, Dong J.   +6 more
europepmc   +1 more source

Sorting Out Sorts

, 1998
openaire   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Quality of Systematic Reviews with Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale. [PDF]

J Clin Med
Ramalho B, Penedones A, Mendes D, Alves C.   +3 more
europepmc   +1 more source

The Direct-Product Decomposition Approach for Symmetry Exploitation in Many-Body Methods in Case of Non-Abelian Point Groups. [PDF]

J Phys Chem A
Hellmann M, Gauss J.
europepmc   +1 more source

Development and Validation of the Visual Medical Scale to Evaluate Nail Psoriasis Severity (ViSENPsO^®). [PDF]

Dermatol Ther (Heidelb)
DaCosta A, de Lélis Filgueiras de Souza C, Minotto R, Shah S, Moshkovich O, Stansbury JP, Yao SL, ViSENPsO Study Group.   +7 more
europepmc   +1 more source

Toward Best Practice Guidelines and Curricula for Virtual Care (Telehealth) in a Cancer Center: Protocol for a Multimethod Study. [PDF]

JMIR Res Protoc
Brownie S, Parkinson-Zarb L, Dimech A, Ftanou M, Broman P.   +4 more
europepmc   +1 more source

Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy. [PDF]

Support Care Cancer
Wech A, Akroyd A, Clayden C, Reynolds LM.   +3 more
europepmc   +1 more source